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Abstract Three novel glycine-rich peptides, named cte-
nidin 1–3, with activity against the Gram-negative
bacterium E. coli, were isolated and characterized from
hemocytes of the spider Cupiennius salei. Ctenidins have a
high glycine content ([70%), similarly to other glycine-
rich peptides, the acanthoscurrins, from another spider,
Acanthoscurria gomesiana. A combination of mass spec-
trometry, Edman degradation, and cDNA cloning revealed
the presence of three isoforms of ctenidin, at least two of
them originating from simple, intronless genes. The full-
length sequences of the ctenidins consist of a 19 amino acid
residues signal peptide followed by the mature peptides of
109, 119, or 120 amino acid residues. The mature peptides
are post-translationally modified by the cleavage of one or
two C-terminal cationic amino acid residue(s) and amida-
tion of the newly created mature C-terminus. Tissue
expression analysis revealed that ctenidins are constitu-
tively expressed in hemocytes and to a small extent also in
the subesophageal nerve mass.
Keywords Ctenidin  Cupiennius salei 
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Introduction
Arthropods, lacking the highly sophisticated adaptive
immune system of vertebrates, rely on their innate immune
system to survive in environments that also harbor many
potentially pathogenic microorganisms. This innate immune
system consists of cellular as well as humoral responses to
invaders. Cellular responses include phagocytosis, nodula-
tion, and encapsulation. Humoral responses include, e.g.,
proteolytic cascades leading to melanization of invaders or
hemolymph coagulation systems, as well as the production
of several different killing factors. These killing factors can
be reactive oxygen species, reactive nitrogen intermediates,
or antimicrobial peptides (AMPs) [1, 2].
AMPs play a key role in innate immunity and are pro-
duced throughout the phylogenetic tree. Despite their
diversity in sequence and structure, they share some
common features, such as small size (generally B10 kDa),
as well as cationic and amphipathic properties [3–6]. Based
on structural features and amino acid composition, AMPs
are usually grouped into three main classes: (1) linear
amphipathic, a-helical AMPs, (2) cyclic or open ended
cyclic AMPs containing cysteine, and (3) AMPs with an
overrepresentation of particular amino acids, such as pro-
line, histidine or glycine. Besides this classical grouping,
there is also another class of AMPs comprised of peptides
that are generated by partial hydrolysis of large precursors
with no antimicrobial properties [7].
Activation of AMP production differs depending on
species. In holometabolous insects, AMPs are produced
predominantly in the fat body, their synthesis is induced
upon infection and they are then released into the hemo-
lymph. In hemimetabolous insects, like termites [8], and
other invertebrates, like mussels [9], shrimps [10], horse-
shoe crabs [11], scorpions [12] or spiders [13, 14], AMPs
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are produced constitutively and stored in hemocyte gran-
ules, and released into the hemolymph [10, 11, 13, 15] and/
or fused with phagocytic vesicles following an infection
[9].
One class of AMPs with an overrepresentation of one
particular amino acid are the glycine-rich peptides. They
are able to inhibit the growth of fungi and have been iso-
lated and characterized from different taxonomic groups,
including plants [16, 17], amphibians [18], and arthropods
[13, 19–21]. The percentage of glycine residues in these
peptides varies considerably, from 10–30% in some species
to more than 60% in the shepherins [17] and acantho-
scurrins [13].
Until now, the immune system of only one spider spe-
cies, the mygalomorph spider Acanthoscurria gomesiana,
has been investigated. From naive hemocytes of this spider,
two different AMPs were isolated, gomesin and acantho-
scurrins. Both are produced constitutively and stored in
granules of hemocytes, from which they can be released
into the hemolymph upon infection. Gomesin is a small,
18-residue AMP forming two disulphide bridges and
adopting a b-hairpin-like structure active against Gram-
positive and Gram-negative bacteria and fungi [14].
Acanthoscurrins are glycine-rich AMPs with a unique
amino acid composition active against Gram-negative
bacteria and yeast. They are 130 and 132 amino acids long,
but are composed of only seven different amino acids,
72–73% of which are glycines [13].
In this study, we present the isolation and character-
ization of ctenidins, a glycine-rich peptide family, from
naive hemocytes of the spider Cupiennius salei. Three
isoforms of the peptide were identified, as well as two of
the three corresponding mRNAs. Mass spectrometry and
cDNA sequence analysis showed that ctenidins result from
the processing of a precursor containing a signal peptide
immediately followed by the mature peptide. Furthermore,
ctenidins were found to be C-terminally amidated. The
genomic organization is simple, containing no introns. We
also show that the ctenidins are mainly expressed in
hemocytes and to a lesser extent in the subesophageal
nerve mass.
Materials and methods
Animals
Mature females of the wandering spider Cupiennius salei
Keyserling were used for the experiments. The spiders
were obtained from a permanent breeding line that has
been maintained for several years. Each C. salei was
housed separately in a 2-l glass jar at a room temperature of
23C and with a light:dark regime of 12:12 h.
Hemolymph collection
The spiders were anesthetized with CO2 and the hemo-
lymph (*300 ll/animal) was collected by cardiac
puncture with a 27G needle on a 1-ml syringe. The
hemolymph was collected in the presence of sodium citrate
buffer, pH 4.6, to prevent coagulation [22]. The hemocytes
were separated from the plasma by centrifugation at 800g
at 4C for 10 min. They were then washed once with
sodium citrate buffer and again centrifuged at 800g at 4C
for 10 min, yielding *1.3 9 107 hemocytes/spider, with
an average weight of 1 ng per hemocyte.
Peptide extraction and purification
The hemocytes collected from the hemolymph of 160
spiders were resuspended in doubly distilled water
(ddH2O) containing 0.1% trifluoroacetic acid (TFA), and
homogenized by ultrasonication (Sonoplus, Bandelin,
Switzerland), which was carried out twice for 1 min at 30%
power, pulse level 5, on ice. Lysed hemocytes were then
centrifuged at 20,800g for 30 min to remove cell debris.
Supernatants were pooled and applied to reversed phase
HPLC (RP-HPLC) on an Atlantis Prep T3 column
(10 9 100 mm, 5 lm; Waters, USA) equilibrated with
ddH2O, 0.1% (TFA). Elution was performed with a step-
wise gradient of 0% acetonitrile (ACN) for 3 column
volumes (CV), 0–22% ACN, 0.1% TFA, in 1.1 CV, 22–
60% ACN, 0.1% TFA, in 15.5 CV, at a flow rate of 2 ml/
min (Fig. 1a).
The active fraction identified by bactericidal assays was
further purified using a nucleosil 100-5 C18 Nautilus
column (4.6 9 250 mm; Macherey & Nagel, Switzerland),
equilibrated with ddH2O, 0.1% TFA, under stepwise
isocratic conditions of 0% ACN, 21% ACN, 0.1% TFA,
and 35% ACN, 0.1% TFA, at a flow rate of 1 ml/min
(Fig. 1b). A final purification using the nucleosil 100-5 C18
Nautilus column (4.6 9 250 mm) was performed with a
stepwise gradient of 0–21% ACN, 0.1% TFA in 0.25 CV
and 21–45% ACN, 0.1% TFA, in 7.2 CV, at a flow rate of
1 ml/min, yielding the ctenidins (Fig. 1c).
HPLC purification was carried out at room temperature
on an Aekta purifier 900 HPLC system (Pharmacia Bio-
tech, Sweden). The column effluent was monitored for
absorbance at 215 nm. All fractions were concentrated
under vacuum, and reconstituted in ddH2O.
RP-HPLC of the ctenidin 1–3 containing fraction
The above marked black bactericidal fraction (Fig. 1c) was
further separated by RP-HPLC on a Reprosil-Pur 300
Phenyl column (2.0 9 100 mm, 5 lm; Dr. Maisch HPLC,
Switzerland) in a Hewlett Packard liquid chromatograph
2788 T. Baumann et al.
1090 (Hewlett Packard) applying a gradient of 10–60%
ACN (80% v/v), 0.1% TFA in 60 min at a flow rate of
0.4 ml/min (Fig. 1d). All peaks were collected as indicated
and characterized by MS.
The samples thus obtained were dissolved in 100 mM
Tris–HCl buffer, pH 7.6 containing 10 mM CaCl2 and
were cleaved with endoproteinase Arg-C (sequencing
grade; Roche Diagnostics) at an enzyme:substrate ratio of
1:50 (w/w) during 18 h at 37C. The peptides were sepa-
rated by RP-HPLC.
Amino acid analysis
Samples were hydrolyzed in the gas phase with 6 M
hydrochloric acid containing 0.1% phenol (by vol) for 22 h
at 115C under N2 vacuum according to Chang and Knecht
[23]. The liberated amino acids were labeled with phen-
ylisothiocyanate and the resulting phenylthiocarbamoyl
amino acids were analyzed by RP-HPLC on a Nova Pak
ODS column (3.9 9 150 mm, 4 lm; Waters) in a Dionex
Summit liquid chromatograph (Dionex) with an automatic
injection system [24].
Amino acid sequence analysis
N-terminal sequence analysis was carried out in a Procise
cLC 492 protein sequencer from Applied Biosystems. The
released PTH amino acids were analyzed on-line by RP-
HPLC.
Mass spectrometry
Electrospray ionization-mass spectrometric (ESI–MS)
analyses were performed on a LTQ Orbitrap XL mass
spectrometer (Thermo Scientific) equipped with a nano-
electrospray ion source, resulting in accurate monoisotopic
masses. Samples were dissolved in ACN/ddH2O (1:1, vol/
vol) containing 1% formic acid. All analyses were carried
out in the positive ion mode. Analysis of digested ctenidins
was performed by matrix assisted laser desorption/ionisa-
tion-time of flight mass spectrometry (MALDI-TOF–MS)
on a VoyagerTM Elite BioSpectrometryTM Research Station
(Applied Biosystems).
Antibacterial assays
The presence of antibacterial activity was determined by a
liquid growth inhibition assay. The bacteria strains used
were Escherichia coli ATCC 25922 and Staphylococcus
aureus ATCC 29213, and the yeast strain was Candida
albicans. Single colonies of bacteria or yeast were picked
and grown in Mueller–Hinton broth (bacteria) or Sabou-
raud-2% dextrose broth (yeast) at 36C overnight. These
cultures were then diluted and grown to the exponential
growth phase, where they were again diluted to a density of
1,000 cells/ml. Then, 90 ll of these suspensions were
transferred to the wells of a 96-well U-bottom microtiter
plate, and 10 ll of the substance to be tested or ddH2O
were added. The plate was incubated at 36C while shaking
Fig. 1 Purification of ctenidins
from C. salei hemocytes.
a Preparative RP-HPLC
chromatogram of hemocyte
lysates. The area in black
corresponds to fraction number
5, which showed activity against
E. coli and S. aureus.
b, c Further separation of the
bactericidal active fraction
(black areas) was done by two
subsequent preparative
RP-HPLC purification steps.
d Small scale RP-HPLC
chromatogram of the active
purified sub-fraction containing
the ctenidins. The numbers of
the peaks correspond to the
numbering of the different
ctenidins
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for 1 h (bacteria) or 2 h (yeast), typically resulting in a
two- to fourfold amplification in cell numbers in the con-
trols. After incubation, the whole 100 ll of each well were
plated on Mueller–Hinton agar plates (bacteria), or Sab-
ouraud-2% dextrose agar plates (yeast) supplemented with
50 lg/ml chloramphenicol and 12.5 lg/ml tetracycline.
After incubation at 36C overnight, the colonies were
counted. MICs were determined and are expressed as (a)–
(b) intervals of concentrations, where (a) is the highest
concentration tested at which the microorganisms are still
growing, and (b) is the lowest concentration at which the
growth is 100% inhibited.
To differentiate between bactericidal or bacteriostatic
activity of the ctenidins, E. coli was incubated in the
presence of ctenidins at its MIC for 16 h at 25C. The
cultures were then plated on Mueller–Hinton agar plates
and colony-forming units counted after an overnight
incubation at 36C.
RNA isolation
Total RNA was isolated from hemocytes using the Abso-
lutely RNA Miniprep Kit (Stratagene, Switzerland) or the
RNeasy Mini Kit (Qiagen, Switzerland). RNA was iso-
lated following the instructions of the manufacturer in the
manual of the kit, including the optional on-column DNA
digestion.
cDNA synthesis
30- and 50-RACE ready cDNAs were synthesized from 1 lg
of the isolated total RNA using the BD SMARTTM RACE
cDNA Amplification Kit (BD Biosciences Clontech). This
system incorporates an anchor sequence (‘‘BD SMART
sequence’’) either at the 30- or the 50- end of the generated
cDNA which can be used as primer binding sites for sub-
sequent RACE PCRs.
30- and 50-RACE PCR
A set of five primers for 30-RACE and five primers for
50-RACE PCR was designed based on the sequence of
acanthoscurrin [13]: Acantho fwd beg 1, Acantho fwd beg
d, Acantho fwd mid 1, Acantho fwd mid 2, Acantho fwd
end 2, Acantho rev mid 1, Acantho rev mid 2, Acantho rev
end 1, Acantho rev end 2, Acantho rev end 3 (Table 1).
These primers were used for PCR with 1/100th of the
synthesized cDNA and the universal primer UPM from the
BD SMARTTM RACE cDNA Amplification Kit, taking
advantage of the BD SMART sequence incorporated into
the cDNAs. PCR was performed for 5 min at 94C, fol-
lowed by 5 cycles of 94C for 30 s, 65C for 30 s, 72C for
1.5 min, 5 cycles of 94C for 30 s, 63C for 30 s, 72C for
1.5 min, 5 cycles of 94C for 30 s, 61C for 30 s, 72C
for 1.5 min, 5 cycles of 94C for 30 s, 59C for 30 s, 72C
Table 1 Primers used in this
study
30-RACE primers
Acantho fwd beg 1 50-TATGGCGGTGGAAGGTATGG-30
Acantho fwd beg d 50-TAYGGHGGHGGHAGRTAYGG-30
Acantho fwd mid 1 50-GGTGGACTCGGAGGCGGC-30
Acantho fwd mid 2 50-GGACTGGGAGGAGGAAAAGGACT-30
Acantho fwd end 2 50-GGATACGGAGGTGGATACGG-30
50-RACE primers
Acantho rev mid 1 50-GCCGCCTCCGAGTCCACC-30
Acantho rev mid 2 50-AGTCCTTTTCCTCCTCCCAGTCC-30
Acantho rev end 1 50-CCGTATCCACCACCACGACC-30
Acantho rev end 2 50-CCGTATCCACCTCCGTATCC-30
Acantho rev end 3 50-GCCTTTGTATTTTCCGCCTCC-30
Ctenidin 50RACE 1 50-TTTTCCAACATATCAAATTATTTT-30
Ctenidin mid rev: 50-CCTACGTCGTCTTTGCCGTCTATTAC-30
Ctenidin Nterm re: 50-GCCGTATCCACCTCCTCTTCTACC-30
Universal primers
UPM 50-CTAATACGACTCACTATAGGGCAAGCAGTGGTATCAACGCAGAGT-30
NUP 50-AAGCAGTGGTATCAACGCAGAGT-30
Genomic primers
Ctenidin sig fwd 50-ATGAAGCATTTGATTCCACTAATTGTAATG-30
Ctenidin gen rev 50-TGTCCTATTACAAATATTAAGTGATGACAG-30
Tissue expression primers
Lycosa S3A fwd 50-CGTAAGGATTGGTACGATGT-30
Lycosa S3A rev 50-TCCATTCCGTGAAAGTTGGT-30
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for 1.5 min, 5 cycles of 94C for 30 s, 57C for 30 s, 72C
for 1.5 min, 5 cycles of 94C for 30 s, 56C for 30 s, 72C
for 1.5 min, 15 cycles of 94C for 30 s, 55C for 30 s,
72C for 1.5 min, and a final elongation at 72C for 7 min.
PCR products were run on a 0.7% agarose gel containing
0.5 ng ethidium bromide/ml. Single bands were cut out
using a scalpel, and DNA was extracted from the gel using
a MinElute Gel Extraction Kit (Qiagen). Then, 1/10th of
the extracted DNA was used as template in another round
of PCR, using the same primers as before and the following
PCR program: 1 min at 95C, followed by 25 cycles of
95C for 30 s, 55C for 30 s, 68C for 1.5 min, and a final
elongation at 68C for 5 min. PCR products were then
purified using the MinElute PCR Purification Kit
(Qiagen).
From the sequencing results of these PCR products,
another primer for 50-RACE PCR was designed: Ctenidin
50RACE 1 (Table 1). 50-RACE PCR was performed with
this primer and the nested universal primer (NUP), using
1/100th of the synthesized cDNA as template and the
following PCR program: 5 min at 94C, followed by 5
cycles of 94C for 30 s, 52C for 30 s, 72C for 1.5 min, 5
cycles of 94C for 30 s, 50C for 30 s, 72C for 1.5 min,
5 cycles of 94C for 30 s, 48C for 30 s, 72C for 1.5 min,
5 cycles of 94C for 30 s, 46C for 30 s, 72C for
1.5 min, 5 cycles of 94C for 30 s, 44C for 30 s, 72C for
1.5 min, 5 cycles of 94C for 30 s, 43C for 30 s, 72C
for 1.5 min, 10 cycles of 94C for 30 s, 42C for 30 s,
72C for 1.5 min, and a final elongation at 72C for 7 min.
The PCR products were purified using the MinElute PCR
Purification Kit.
Another primer for 50-RACE PCR was designed based
on the sequencing results from the products of the above
PCR, Ctenidin mid rev (Table 1). 50-RACE PCR was
performed with this primer and the nested universal primer
NUP, using 1/100th of the synthesized cDNA as template
and the following PCR program: 5 min at 94C, followed
by 5 cycles of 94C for 30 s, 53C for 30 s, 72C for
1.5 min, 5 cycles of 94C for 30 s, 52C for 30 s, 72C for
1.5 min, 20 cycles of 94C for 30 s, 51C for 30 s, 72C
for 1.5 min, and a final elongation at 72C for 7 min. PCR
products were run on a 1% low-melt agarose gel containing
0.5 ng ethidium bromide/ml. Single bands were cut out
using a scalpel, and DNA was extracted from the gel using
a MinElute Gel Extraction Kit (Qiagen). Half of the
extracted DNA was then used as template in another round
of PCR, using the same primers and PCR program
as before. PCR products were then purified using the
MinElute PCR Purification Kit (Qiagen).
To completely solve the sequence, yet another primer
for 50-RACE PCR had to be designed based on the
sequencing results from the products of the above PCR,
Ctenidin Nterm re (Table 1). This primer was used together
with the universal primer UPM for 50-RACE PCR with
1/100th of the synthesized cDNA as template. The fol-
lowing PCR program was used: 5 min at 94C, followed by
5 cycles of 94C for 30 s, 68C for 30 s, 72C for 1.5 min,
5 cycles of 94C for 30 s, 65C for 30 s, 72C for 1.5 min,
5 cycles of 94C for 30 s, 63C for 30 s, 72C for
1.5 min, 5 cycles of 94C for 30 s, 61C for 30 s, 72C for
1.5 min, 5 cycles of 94C for 30 s, 59C for 30 s, 72C
for 1.5 min, 10 cycles of 94C for 30 s, 57C for 30 s, and
a final elongation at 72C for 7 min. The PCR products
were purified using the MinElute PCR Purification Kit
(Qiagen).
Cloning and sequencing
Purified PCR products were cloned into pDrive vector
using the QIAGEN PCR Cloning Kit. The products in the
pDrive vector were sequenced using the BigDye Termi-
nator v3.1 Cycle Sequencing Kit. Sequences were
separated on an ABI3130XL automated sequencer using
POP7 polymer on a 50-cm array and acquired using
sequence detection software v.3.0 (all from Applied Bio-
systems). Sequences were analyzed with BioEdit v7.0.8
software and putative signal peptides were analyzed using
the prediction server SignalP 3.0 (http://www.cbs.dtu.dk/
services/SignalP).
DNA isolation
Genomic DNA was isolated from hemocytes of two adult
female C. salei, using the DNeasy Blood & Tissue Kit
(Qiagen). Isolation was carried out following the manu-
facturer’s protocol for cultured cells.
Genomic PCR
PCR was carried out with 1/200th of the isolated genomic
DNA as template. The primers used were Ctenidin sig fwd
and Ctenidin gen rev. The PCR program was 94C for
3 min, followed by 35 cycles of 94C for 30 s, 42C for
30 s, 72C for 1 min and a final elongation at 72C
for 2 min. PCR products were analyzed on a 1.5% agarose
gel containing 0.5 ng ethidium bromide/ml.
Tissue expression analysis
Various tissues (ovaries, subesophageal nerve mass,
hepatopancreas, venom glands, heart, silk glands, hemo-
cytes, and muscle) were extracted from CO2 anesthetized,
unchallenged female C. salei. Total RNA was extracted
from these tissues using the RNeasy Mini Kit (Qiagen).
1 lg of total RNA was reverse-transcribed into cDNA
using the BD SMARTTM RACE cDNA Amplification Kit.
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The amount of template used for expression analysis was
normalized according to the band intensity values obtained
with the ribosomal protein S3A transcript as control.
Primers used for this control PCR were Lycosa S3A fwd and
Lycosa S3A rev (Table 1), based on the sequence of Lycosa
singoriensis S3A transcript (GenBank EU 247153.1). The
primers used for the expression analysis of ctenidin were
Ctenidin sig fwd and Ctenidin mid rev (Table 1). The PCR
program was 3 min at 94C, followed by 33 cycles of 94C
for 30 s, 44C for 30 s, 72C for 30 s, and a final elongation
at 72C for 2 min. PCR products were run on a 2% agarose
gel containing 0.5 ng ethidium bromide/ml. Band intensities
were quantified using the ImageMaster VDS 3.0 software
(Pharmacia Biotech, Sweden).
Results
Purification of antimicrobial peptides from hemolymph
In searching for antimicrobially active peptides produced
by the spider C. salei as immune defense, we isolated
hemocytes from the hemolymph of mature female spiders
by centrifugation. The peptides from the hemocytes were
extracted under acidic conditions after disrupting the cells
by sonication. The acidic extract was directly submitted to
RP-HPLC, resulting in 15 fractions that were tested for
antimicrobial activity in antibacterial assays. Fraction
number 5 showed activity against both the Gram-negative
E. coli and the Gram-positive S. aureus (Fig. 1a, black
area). Since the fraction contained several peptides, it was
further separated by two RP-HPLC steps as described in
material and methods (Figs. 1b and c), observing activities
of the sub-fractions (black areas) by liquid growth inhibi-
tion assays, finally yielding an active fraction containing
three peptides which could not be separated further on a
large scale (Fig. 1d).
Characterization
The three peptides were analyzed by high resolution MS,
resulting in the monoisotopic molecular masses of
8,810.022, 9,507.372 and 9,564.373 Da. However,
sequencing of the three combined peptides by Edman-
degradation revealed only a single N-terminal sequence,
DRGYGGGRRGGGYGGGGYGG. The sequence had a
high glycine residue content, and the assignment of the
sequence became ambiguous after 20 amino acid residues
due to the increased lag. Amino acid analysis revealed a
unique composition consisting of more than 71% Gly, and
only eight other amino acids, Asx (3.5%), Glx (1.4%), Arg
(5.2%), Tyr (8.6%), Val (2.6%), Ile (0.9%), Leu (4.0%),
and Lys (2.6%).
Cloning and sequencing
Based on the first 20 amino acids, a set of degenerate
primers was designed for 30-RACE PCR of hemocyte
cDNA. Another set of primers for 30- as well as 50-RACE
PCRs was designed based on the sequence of acantho-
scurrin, a glycine-rich AMP isolated from the hemocytes of
the mygalomorph spider A. gomesiana [13]. This second
set of primers was designed because of similarities in the
amino acid sequences and the amino acid compositions
between the peptides and acanthoscurrin. With these
primers, hemocyte cDNA was screened for glycine-rich
sequences. While the degenerate primers did not yield any
sequences, one of the 30-RACE primers from the
acanthoscurrin sequence yielded the C-terminus of one of
the glycine-rich peptides. By primer walking sequencing,
the whole cDNA sequences of two of the three peptides
were identified. We named these peptides ctenidin 1 and 2,
adapted from Ctenidae, the family name of the spider
C. salei. The ctenidin 1 cDNA consists of 771 bp, starting
with a 30-UTR of 53 bp, followed by an open reading
frame (ORF) of 423 bp, a 50-UTR of 270 bp, and the poly-
A tail. The ctenidin 2 cDNA is identical, except that 30 bp
are missing in the ORF of ctenidin 2 compared to ctenidin
1 (Fig. 2). The deduced amino acid sequences of the two
peptides start with a putative signal peptide of 19 amino
acids, the cleavage site for the signal peptidase most likely
being located after the alanine residue preceding the
aspartic acid in position 20, as predicted by SignalP 3.0
software (data not shown). The sequence following the
signal peptide overlapped with the sequence obtained by
Edman-degradation of the peptides. The calculated mono-
isotopic masses of 8,996.099 and 9,693.414 Da for the two
peptides differed from the measured masses of 8,810.022
and 9,507.372 Da by 186.077 or 186.042 Da, respectively.
This mass difference corresponds to the lack of the two C-
terminal amino acids, a glycine and a lysine, due to the
posttranslational amidation process of the C-terminal gly-
cine of the mature peptides (differences between measured
and calculated masses after processing: 0.023 or 0.059 Da,
respectively). Mature ctenidin 1 is composed of 119 amino
acid residues and ctenidin 2 comprises 109 amino acid
residues.
Characterization of full-length peptides
To confirm this, the three peptides were separated by RP-
HPLC on a small scale (Fig. 1b) and each was incom-
pletely digested with the endoproteinase Arg-C. The
resulting fragments were separated by RP-HPLC, and
MALDI-TOF–MS of all fragments was performed. The
resulting masses of the C-terminal fragments (1,896.8 Da,
average mass) confirmed the hypothesis that the C-terminal
2792 T. Baumann et al.
lysine and glycine are cleaved off post-translationally. The
glycine likely contributes to the amidation of the preceding
glycine in both ctenidins, the amidation being shown by the
monoisotopic masses of the mature peptides. By the same
method, the amino acid sequence of the third peptide,
which we named ctenidin 3, was determined. The frag-
ments generated by Arg-C digestion revealed two
additional glycines in the N-terminal region of ctenidin 3
compared to ctenidins 1 and 2, resulting in a fragment of
2,353.8 Da (average mass) instead of 2,239.2 Da (average
mass), and a slightly different C-terminus (Fig. 3a). The
C-terminal glycine of ctenidin 1 and 2 is missing in cte-
nidin 3; instead, it ends with a tyrosine, the resulting mass
of the C-terminal fragment being 1,840.1 Da (average
mass). Like ctenidin 1 and 2, ctenidin 3 is C-terminally
amidated, as evidenced by the monoisotopic mass of the
mature peptide. The position of the additional glycines
in the N-terminal region was determined by Edman-
degradation of the corresponding fragment. The rest of the
amino acid sequence is identical to that of the other
ctenidins.
Tissue expression
Various spider tissues were isolated and the expression of
ctenidin mRNA in them was determined using semi-
quantitative RT–PCR. The tissue cDNAs were normalized
against the transcript of the ribosomal protein S3A, and a
primer pair detecting all three ctenidins was used. Only
hemocytes showed an abundant expression of ctenidin
mRNA, while subesophageal nerve mass showed little
expression. No expression was detected in the remaining
tissues (Fig. 4).
Gene structure
Genomic PCR was performed to solve gene structure of the
ctenidins. The resulting PCR product had the same size as
1- TTTTAATTTCGTCACATTCCTGAGTACGAAGTCAAACCCTCTGAGGAACCAAA - 53
54- ATGAAGCATTTGATTCCACTAATTGTAATGGCCAGTGTCGTACTTGCCGTATACGCAGAC -113
M K  H  L  I  P  L  I  V  M  A  S  V  V  L  A  V  Y  A D
114- AGAGGATACGGCGGTGGTAGAAGAGGAGGTGGATACGGCGGAGGCGGATACGGCGGCGGC -173
R  G  Y  G  G  G  R  R  G  G  G  Y  G  G  G  G  Y  G  G  G
174- GGATACGGCGGTGGAGGCGGCGGATACGGTGGTGGAGTAGGAGGCGGCAGAGGAGGCGGA -233
G  Y  G  G  G  G  G  G  Y  G  G  G  V  G  G  G  R  G  G  G
234- GGAGGATTAGGAGGCGGAAGAGGAGGTGGAGGAGGAGTAATAGACGGCAAAGACGACGTA -293
G  G  L  G  G  G  R  G  G  G  G  G  V  I  D  G  K  D  D  V
294- GGACTTGGCGGTGGCGGATATGGTGGAGGATTAGGAGGCGGCCAAGGAGGCGGAGGAGGA -353
G  L  G  G  G  G  Y  G  G  G  L  G  G  G  Q  G  G  G  G  G
354- TTAGGAGGCGGCCAAGGAGGCGGAGGAGGATTAGGAGGCGGCCGAGGAGGTGGTGGATAT -413
L  G  G  G Q  G  G  G  G  G  L  G  G  G R G  G  G  G  Y
414- GGTGGTGGTGGTGGAGGATATGGAGGAGGCAAATATGGAGGAGGCAAATACGGAGGAAAA -473
G  G  G  G  G  G  Y  G  G  G  K  Y  G  G  G  K  Y  G G  K
474- TAATTTGATATGTTGGAAAATAACGTTTCAAGAAATATAATTCCCCATTTAGATGTTTCC -533
***
534- GCGCCTACAAATACCTGCCATGTTCTTAAGAAAACTGTCATCACTTAATATTTGTAATAG -593
594- GACATTAGTTTATATTCCTATTTGTAATAGGATATTAGTTAATGAAAGCAATTATTAATT -653
654- ATCAATTATTAATTATTTCGATAAGCATGTAAATGATTTAAAAGCTTTTAGCAGTTTGTA -713
714- AAATGGTGCACGTAATAAAATATGTTATTCGTGAAAAAAAAAAAAAAAAAAAAAAAAA -771
Fig. 2 Ctenidin 1 and 2 cDNA
sequences. The deduced amino
acid sequence is presented
under the nucleotide sequence.
The mature peptide sequence is
underlined; the part missing in
ctenidin 2 is double underlined.
The nucleotide sequence of the
mature peptide is in bold. The
dotted line marks the post-
translationally cleaved off
lysine and the glycine residue
involved in C-terminal
amidation of the other glycine.
Asterisks mark the stop codon.
The polyadenylation signal is
shown in bold italics
a
b
Ctenidin 1   1 DRGYGGGRRGGGYGGGGYG--GGGYGGGGGGYGGGVGGGRGGGGGLGGGRGGGGGVIDGK   58
Ctenidin 2   1 DRGYGGGRRGGGYGGGGYG--GGGYGGGGGGYGGGVGGGRGGGGGLGGGRGGGGGVIDGK   58
Ctenidin 3   1 DRGYGGGRRGGGYGGGGYGGGGGGYGGGGGGYGGGVGGGRGGGGGLGGGRGGGGGVIDGK   60
Ctenidin 1  59 DDVGLGGGGYGGGLGGGQGGGGGLGGGQGGGGGLGGGRGGGGYGGGGGGYGGGKYGGGKYG 119
Ctenidin 2  59 DDVGLGGGGYGGGLGGGQGGGGGLGGG----------RGGGGYGGGGGGYGGGKYGGGKYG 109
Ctenidin 3  61 DDVGLGGGGYGGGLGGGQGGGGGLGGGQGGGGGLGGGRGGGGYGGGGGYGGGGKYGGGKY- 120
Ctenidin 1 1 --DRGYGGGRRGGGYGGGGYGGGGYGGGGGGYGGGVGGGRGGGGGLGGGRGGGGGVIDGKDDVGLG 64
Acantho 1 1 DVYKGGGGGRYGGGRYGGGGGYGGGLGGGGLGGGGLGGGKGLGGGGLGGGGLGGGGLGGGGLGGGK 66
Ctenidin 1 65 GGGYGGGLGGGQGGGGGLGGGQGGGGGLGGGRGGGGYGGGGGGYGGGKYGGGKYG----------- 119
Acantho 1 67 GLGGGGLGGGGLGGGGLGGGGLGGGKGLGGGGLGGGGLGGGRGGGYGGGGGYGGGYGGGYGGGKYK 132
Fig. 3 Comparisons of the three mature ctenidins and of ctenidin 1 to
acanthoscurrin 1. a Alignment of the three mature ctenidins. The
fragment of ctenidin 3 that was sequenced by Edman-degradation to
determine the position of the additional glycines is underlined. The
fragments used to prove the C-terminal processing are underlined by
a dotted line. b Comparison of ctenidin 1 to acanthoscurrin 1. All
glycine-repeats are highlighted in gray
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the ctenidin 1 PCR product obtained with cDNA as tem-
plate, suggesting that there are no introns in the ORF of
ctenidin 1 (Fig. 5). This was confirmed by sequencing,
which showed the same sequences for products obtained
from DNA and from mRNA. Interestingly, genomic PCR
yielded the sequence of ctenidin 1, but also of ctenidin 3, of
which the cDNA sequence had not been solved (Fig. 6).
Similarly to ctenidin 1, the gene sequence of ctenidin 3 did
not contain any introns. Sequencing revealed a slightly
different C-terminus for ctenidin 3. Compared to ctenidin 1
and 2, it contained a point mutation resulting in the
mutation of the last glycine in the mRNA sequence to an
arginine. The deduced amino acid sequence showed a
difference of 342.20 Da to the measured mass of ctenidin
3, which is explained by the post-translational processing
of the C-terminus. In the case of ctenidin 3, the two
C-terminal cationic residues Arg and Lys are removed,
with the remaining Gly used to amidate the preceding Tyr,
resulting in the C-terminus of the mature peptide. This also
explains the slightly different C-terminus of ctenidin 3
compared to ctenidin 1 and 2. On the other hand, genomic
PCR did not yield the ctenidin 2 sequence, which was
clearly observed in PCR with cDNA (Fig. 5).
Antimicrobial activity
To investigate the antimicrobial activity of the ctenidins,
the mixture of the three peptides isolated from hemocytes
was quantified by Edman degradation. From a total of 150
spiders, 261.5 lg ctenidins were isolated. The anti-
microbial activity of the ctenidins was tested against the
following three test organisms: E. coli (Gram-negative
bacterium), S. aureus (Gram-positive bacterium), and
C. albicans (yeast). The ctenidins showed activity against
E. coli with a MIC of 2.5–5 lM. The growth of S. aureus
was clearly reduced in the presence of ctenidins compared
to the control group, but not inhibited in the range of the
concentrations tested (up to 10 lM). Due to lack of
material, no higher concentrations could be tested. No
activity was detected in the range of the concentrations
tested (up to 5 lM) against C. albicans.
When E. coli was incubated in the presence of ctenidins
at its MIC of 5 lM for 16 h, a full growth recovery was
Fig. 4 RT-PCR analysis of ctenidin-gene expression in different
tissues. Expression was assayed in ovaries (A), subesophageal nerve
mass (B), hepatopancreas (C), venom glands (D), heart (E), silk
glands (F), hemocytes (G), and muscle (H)
Fig. 5 Ctenidin gene structure. PCR products of hemocyte cDNA
and genomic DNA with ctenidin-specific primers. The 100-bp
molecular weight marker is marked with MW; band sizes are in bp
1- ATGAAGCATTTGATTCCACTAATTGTAATGGCCAGCGTCGTACTTGCCGTCTACGCAGAC - 60
M K  H  L  I  P  L  I  V  M  A  S  V  V  L  A  V  Y  A D
61- AGAGGATACGGCGGTGGTAGAAGAGGAGGTGGATACGGCGGAGGCGGATACGGCGGTGGA -120
R  G  Y  G  G  G  R  R  G  G  G  Y  G  G  G  G  Y G G  G
121- GGCGGCGGATACGGCGGTGGAGGCGGCGGATACGGTGGTGGAGTAGGAGGCGGCAGAGGA -180
G  G G  Y  G  G  G  G  G  G Y  G  G  G  V  G  G  G  R  G
181- GGCGGAGGAGGATTAGGAGGCGGAAGAGGAGGTGGAGGAGGAGTAATAGACGGCAAAGAC -240
G  G G  G  L  G  G  G  R  G G  G  G  G  V I  D  G  K  D
241- GACGTAGGACTTGGCGGTGGCGGATATGGTGGAGGATTAGGAGGCGGCCAAGGAGGCGGA -300
D  V G  L  G  G  G  G  Y  G G  G  L  G  G  G  Q  G  G  G
301- GGAGGATTAGGAGGCGGCCAAGGAGGCGGAGGAGGATTAGGAGGCGGCCGAGGAGGTGGT -360
G  G  L  G  G  G  Q  G  G  G  G  G L  G  G  G  R G  G  G
361- GGATATGGTGGTGGTGGTGGAGGATATGGAGGAGGCAAATATGGAGGAGGCAAATACGGA -420
G  Y G  G  G  G  G  G  Y  G G  G  K  Y  G  G  G  K  Y G
421- AGAAAATAA -429
R K ***
Fig. 6 Ctenidin 3 ORF gene sequence. The deduced amino acid
sequence is presented under the nucleotide sequence. The mature
peptide sequence is underlined. The nucleotide sequence of the
mature peptide is in bold. The dotted line marks the post-translation-
ally cleaved off lysine and the glycine residue involved in C-terminal
amidation of the other glycine. The additional glycines compared to
ctenidin 1 and 2 are double underlined. Silent mutations are
highlighted in light gray, the mutation causing a Gly-Arg exchange
is highlighted in black. Asterisks mark the stop codon
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observed, hinting at bacteriostatic rather than bactericidal
activity.
Discussion
We report here for the first time the purification and
characterization of an AMP from hemocytes of an aran-
eomorph spider, C. salei. So far, investigations on the
immune system of spiders have been limited to the my-
galomorph species A. gomesiana [13–15, 25]. Three
isoforms of the AMP named ctenidin were identified.
Ctenidins are linear, cationic peptides, possessing a net
charge of ?5 (not taking into account the C-terminal am-
idation). With more than 70% glycine residues, ctenidins
clearly represent new members of the family of glycine-
rich AMPs. As seen in other glycine-rich AMPs, only a few
amino acids make up the peptide. In the case of the cte-
nidins, these are Gly (71.2%), Asp (3.5%), Gln (1.4%), Arg
(5.2%), Tyr (8.6%), Val (2.6%), Ile (0.9%), Leu (4.0%),
and Lys (2.6%). This composition resembles the compo-
sition of acanthoscurrins isolated from A. gomesiana.
Interestingly, acanthoscurrins exhibit 1.7 times more
hydrophobic amino acid residues (mainly Leu) than the
ctenidins, but 4 times less Asp. While related to acantho-
scurrins, ctenidins show considerable structural differences
to other glycine-rich peptides (Table 2), as has been
reported before for the glycine-rich AMPs [13, 19].
While a complete sequencing of the ctenidins by Edman
degradation was not possible, the full sequences of the
ctenidins were identified by screening hemocyte cDNA for
glycine-rich sequences. Within this context, it is worth
mentioning that the sequence of the ctenidins with its many
glycine repeats led to problems in PCR, yielding many
truncated products, probably due to a ‘sliding’ of the
polymerase caused by the glycine repeats. Two of the
ctenidins identified, ctenidin 1 and 2, are almost identical
on the peptide and nucleotide level, except for a sequence
of ten amino acids missing in ctenidin 2. The third isoform,
ctenidin 3, differs by two additional glycines inserted in the
N-terminal part of the peptide, a slightly different C-ter-
minus, and two additional silent point mutations on the
nucleotide level (Fig. 6), as well as some point mutations
in the 30-UTR (not shown). The full-length peptides overall
resemble the acanthoscurrins, mainly due to the repeats of
3–6 glycines, mostly interrupted by a single different
amino acid (Fig. 3b). But despite this resemblance, the
peptides show only a few sequence similarities. This leaves
the question open as to whether the peptides originate from
a common ancestor or have evolved independently,
although the latter case seems rather unlikely when
comparing the peptides. An interesting feature that distin-
guishes the ctenidins from the acanthoscurrins is the
presence of a ten amino acid residues-long sequence in the
middle of the peptide, VIDGKDDVGL, which interrupts
the glycine repeats. The function of this sequence is not
clear, as it gives the ctenidins a local negative charge,
flanked on either side by hydrophobic amino acid residues.
Comparisons of the calculated and the measured masses
of the mature peptides suggest the cleavages of the last two
(ctenidin 1 and 2) or three (ctenidin 3) C-terminal amino
acids, the glycine being involved in the amidation of the
preceding amino acid (another glycine or tyrosine). This is a
mechanism also identified in spider venom toxins [26, 27].
It is probable that the C-terminal basic arginine or lysine
residue could be removed in a first processing step by a
Table 2 Structural comparison among glycine-rich antimicrobial peptides
Peptides Molecular masses (Da) pI G (%) K ? R (%) H (%) Hydrophobic residues (%)
Ctenidin 1 9,514 9.6 71.4 7.5 0.0 7.5
Ctenidin 2 8,816 9.6 70.6 8.3 0.0 7.6
Ctenidin 3 9,571 9.6 71.6 7.5 0.0 7.5
Acantho 1 10,226 9.9 72.9 6.8 0.0 12.8
Acantho 2 10,112 9.9 72.5 6.9 0.0 13.0
Armadillidin 5,260 12.0 47.2 11.1 11.1 18.9
AFP 7,118 6.7 31.3 4.5 20.9 4.5
Holotricin 3 6,838 7.4 63.9 1.2 15.7 6.0
Tenecin 3 7,323 7.5 44.2 0.0 19.5 9.1
Shepherin 1 2,362 7.3 67.9 0.0 28.6 0.0
Shepherin 2 3,259 7.3 65.8 0.0 21.1 0.0
Modified from Herbinie`re et al. [19]
Antibacterial peptides from insects: AFP, holotricin 3 and tenecin 3 [47, 48, 51]; from spider: acanthoscurrins 1 and 2 [13]; from woodlice:
armadillidin [19]; and from plants: shepherin 1 and 2 [17]. Molecular masses (average) and pI were calculated using
http://www.expasy.org/tools/protparam.html
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basic residue-specific carboxypeptidase. In a second step,
the remaining glycine-extended peptide would be converted
into a des-Gly peptide amine by a-amidation [28]. A similar
amidation signal of X-Gly-Arg/Lys-Arg/Lys is also found
in scorpion toxins [29, 30]. Post-translational amidation of
the C-terminus is a common modification of AMPs of
chelicerates and crustaceans [13, 14, 19, 31, 32], making the
peptides more stable and raising their positive net charge, an
important feature of most AMPs.
Ctenidins are synthesized as prepeptides containing a
signal peptide of 19 amino acid residues, directly followed
by the mature peptide (Figs. 2 and 6). The presence of the
signal peptides makes it likely that the ctenidins are
directed to and stored in hemocyte granules. This is a
common process in invertebrates, as has been identified in
other spider AMPs [15, 33], as well as in shrimps [10],
limulids [34], mussels [9], and termites [8]. The content of
these granules can then be released into the hemolymph
upon infection or fuse with phagocytic vesicles inside the
hemocytes.
Tissue expression of ctenidins determined by RT–PCR
revealed that they are constitutively expressed in hemo-
cytes, which is in agreement with the above-mentioned
mechanism. Of the remaining tissues, only the subesopha-
geal nerve mass showed a weak expression, and no signal
was detectable in the other tissues (Fig. 4). This contrasts
somewhat with the other spider AMPs, which are exclu-
sively expressed in hemocytes [13, 33]. Tachyplesin, an
AMP from horseshoe crabs, is also expressed mainly in
hemocytes, but to a lesser extent also in the brain [34], like
the ctenidins. Also, other AMPs of invertebrates can be
expressed in nervous tissues [35].
The gene structure of the ctenidin genes is very simple,
showing no introns in the so far identified genes of the long
isoforms ctenidin 1 and 3 (Fig. 5). Since ctenidin 1 and 2
are identical except for a missing piece in ctenidin 2,
alternative splicing of mRNA from the same gene could
have been the cause of the two isoforms. This mechanism
was disproved since there are no introns. Either ctenidin 2
originates from its own gene, which we were not able to
amplify, or it is generated by a so far unknown RNA
processing mechanism other than splicing from the cteni-
din 1 gene. The two identified genes have likely evolved
from gene duplication events during the evolution of
C. salei, as it is also described for a duplicated Ultrabi-
thorax (Ubx) gene [36] or three Hox genes (Dfd, Scr, and
Ubx) [37] of this spider.
Ctenidins showed activity against E. coli at a MIC of
2.5–5 lM, similar to that of acanthoscurrins. When incu-
bated for 16 h, the growth of E. coli had recovered. This
indicates that ctenidins act in a bacteriostatic rather than
bactericidal manner, although the lack of material did not
allow us to confirm this observation by raising the ctenidin
concentration. The loss of activity after a given time might
be due to degradation of the peptides. The targets of gly-
cine-rich peptides in bacteria and fungi are not clear, but
can be diverse. Besides the classical membrane disruption
or its depolarization [38], ctenidins could inhibit intracel-
lular components as mentioned for proline-rich peptides
[39] or could hamper bacterial cell division as suggested
for the glycine- and proline-rich coleoptericins [40].
Another glycine-rich peptide family, the attacins, exerts its
activity against Gram-negative bacteria by inhibiting the
synthesis of an outer membrane protein by interfering with
the transcription of its genes [41]. Finally, the proline-rich
pyrrhocoricin inhibits the ATPase activity of the bacterial
heat shock protein DnaK, thereby preventing chaperone-
assisted protein folding [42]. No structures of truly glycine-
rich peptides are available, making it difficult to predict a
target or functional mechanism of such peptides. While a
recent report suggests a b-sheet structure for the C-terminal
part of acanthoscurrin [43], the cationic plasticins, glycine-
leucine-rich peptides from frog skin, were shown to go
through multiple conformational transitions, including
helix states, b-structures, and disordered states [44]. We
had to measure the combined MIC of the three ctenidin
isoforms as not enough material was present to separate the
peptides on a larger scale to obtain enough material for
separate tests. The three isoforms were approximately
present in a 1:1:1 ratio, as judged by the chromatogram of
the analytical separation (Fig. 1d). Since their sequences
are so similar, we expect the MICs of the single isoforms to
differ only marginally, if at all. The growth of the Gram-
positive bacterium S. aureus was slowed down in the
presence of ctenidins to about 30% of the normal growth
(data not shown), but was not completely inhibited. This
selective activity against Gram-negative bacteria is in
agreement with other glycine-rich AMPs [13, 45]. The
specificity for Gram-negative bacteria might be due to the
composition of their outer membrane. Positively charged
amino acid residues might bind specifically to components
of the outer membrane of Gram-negative bacteria, like the
glycolipid lipopolysaccharide, as has been shown for
the bactericidal/permeability-increasing (BPI)/lipopoly-
saccharide-binding protein (LBP) protein family [46].
Specificity might also be mediated by the inhibition of the
synthesis of Gram-negative-specific proteins [41]. In con-
trast, armadillidin, a glycine-rich AMP isolated from the
woodlouse Armadillidium vulgare, showed activity against
the Gram-positive bacterium B. megaterium but not against
Gram-negative bacteria [19]. Rather surprisingly, no
activity of ctenidins was detected against the yeast
C. albicans up to the tested concentration of 5 lM,
whereas the acanthoscurrins exhibit fungicidal activities at
a MIC of 1.3–2.6 lM. The 22 amino acid residues peptide
leptoglycin, isolated from skin secretions of the frog
2796 T. Baumann et al.
Leptodactylus pentadactylus, exhibits high sequence simi-
larities to the ctenidins and is also only active against
Gram-negative bacteria, but not against either Gram-posi-
tive bacteria or fungi [45]. Most other glycine-rich AMPs
are active against yeast [13, 17, 47, 48], with few excep-
tions [49], and several plant glycine-rich peptides are
induced by wounding or fungal infection and are therefore
considered to be defense-related proteins [50].
Conclusions
In conclusion, we have shown that the spider C. salei
expresses three isoforms of a glycine-rich AMP that we
named ctenidins. Two of the isoforms originate from their
own genes, while a gene for ctenidin 2 was not detected.
While RNA splicing can be ruled out, it is possible that its
mRNA is generated by an unknown processing mechanism
from the ctenidin 1 mRNA. Ctenidins are constitutively
expressed in hemocytes and nervous tissue, thus their
expression is independent of immune challenges. They are
active against E. coli and are therefore assumed to be
generally active against Gram-negative bacteria. Future
research will focus on the identification of further antimi-
crobial compounds of the spider immune system and
possible synergistic interactions among the ctenidins
themselves and with other compounds to shed light on how
the innate immune system of spiders deals efficiently with
different kinds of invaders.
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